Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model

Journal of Digestive Diseases

Volumn 13, Issue 8, 2012, Pages 421-429

  Zhu, Mei Ying ^a   Lu, Yun Min ^a   Ou, Yang Xiao ^a   Zhang, Hui Zhen ^a   Chen, Wei Xiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Colitis; Cytokines; Fibrosis; Inflammatory bowel disease; Trinitrobenzenesulfonic acid

Indexed keywords

ALCOHOL; COLLAGEN; CYTOKINE; ENEMA; EOSIN; HEMATOXYLIN; INTERLEUKIN 17; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CHRONIC DISEASE; COLITIS; COLON; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HISTOLOGY; INFLAMMATION; INTESTINAL FIBROSIS; MICROSCOPY; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; TH1 CELL; TH17 CELL; TH2 CELL;

ANALYSIS OF VARIANCE; ANIMALS; CHRONIC DISEASE; COLITIS; COLLAGEN TYPE I; COLLAGEN TYPE III; COLON; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINES; FEMALE; FIBROSIS; GENE EXPRESSION; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-4; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SMAD3 PROTEIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863860108     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2012.00607.x     Document Type: Article

References (27)

1. Bonniaud P, Margetts PJ, Ask K, Flanders K, Gauldie J, Kolb M. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 2005; 175: 5390-5.
2. Latalla G, Sferra R, Vetuschi A etal. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2, 4, 5-trinitrobenzene sulphonic acid. Eur J Clin Invest 2008; 38: 410-20.
3. Wengrower D, Zanninelli G, Pappo O etal. Prevention of fibrosis in experimental colitis by captopril: the role of TGF-β1. Inflamm Bowel Dis 2004; 10: 536-45.
4. Rieder F, Brenmoehl J, Leeb S, Schölmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut 2007; 56: 130-9.
5. Rieder F, Fiocchi C. Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 2009; 6: 228-35.
6. Fitzpatrick LR, Meirelles K, Small JS, Puleo FJ, Koltun WA, Cooney RN. A new model of chronic hapten-induced colitis in young rats. J Pediatr Gastroenterol Nutr 2010; 50: 240-50.
7. Fichtner-Feigl S, Fuss IJ, Young CA etal. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2, 4, 6-trinitrobenzene sulfonic acid colitis. J Immunol 2007; 178: 5859-70.
8. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
9. Wang H, Ouyang Q, Hu RW. Establishment of rat colitis model induced by trinitrobenzenesulfonic acid. Chin J Gastroenterol 2001; 6: 7-10 (in Chinese).
10. Alex P, Zachos NC, Nguyen T etal. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009; 15: 341-52.
11. te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 2006; 12: 995-9.
12. Zheng L, Gao ZQ, Wang SX. A chronic ulcerative colitis model in rats. World J Gastroenterol 2000; 6: 150-2.
13. Lund PK, Rigby RJ. What are the mechanisms of fibrosis in IBD? Inflamm Bowel Dis 2008; 14 Suppl 2: S127-8.
14. Pohlers D, Brenmoehl J, Löffler I etal. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta 2009; 1792: 746-56.
15. Latella G, Vetuschi A, Sferra R etal. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis. Eur J Clin Invest 2009; 39: 145-56.
16. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004; 85: 47-64.
17. Videla S, Vilaseca J, Medina C etal. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis. J Pharmacol Exp Ther 2006; 316: 940-5.
18. Sinha S, Hoofnagle MH, Kingston PA, McCanna ME, Owens GK. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 2004; 287: C1560-8.
19. Zanninelli G, Vetuschi A, Sferra R etal. Smad3 knock-out mice as a useful model to study intestinal fibrogenesis. World J Gastroenterol 2006; 12: 1211-8.
20. Haydont V, Mathé D, Bourgier C etal. Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. Radiother Oncol 2005; 76: 219-25.
21. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909-22.
22. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189: 1169-80.
23. Kadivar K, Ruchelli ED, Markowitz JE etal. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients. Inflamm Bowel Dis 2004; 10: 593-8.
24. Theiss AL, Simmons JG, Jobin C, Lund PK. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem 2005; 280: 36099-109.
25. Fujino S, Andoh A, Bamba S etal. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70.
26. Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 2010; 31: 561-72.
27. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-89.